Omega-3 is an essential oil required by the body for proper functioning. It protects from cardiovascular diseases and improves the development and functioning of the skin as well nervous and visual system. Astaxanthin is a carotenoid pigment and is one of the most effective antioxidants to support human health.
The global demand for Omega-3 and Astaxanthin for human consumption will require large quantities of both products:
260.000 tonnes of Omega-3 and 670 tonnes of Astaxanthin per year. This growing demand comes mainly from health conscious customer segment. This segment is also very interested in buying natural and eco-friendly products.
However, their traditional extraction process from marine organisms (mainly fish and krill) is not sustainable: over fishing, high energy, raw materials consumption and a low efficiency. The majority of the marine resources are fully exploited or overexploited.
The SME Neoalgae has designed an eco-innovative and sustainable industrial bioprocess for obtaining Omega-3 and Astaxanthin using marine microalgae as a natural source. This system is the answer to the growing demand in Omega-3 and Astaxanthin, especially in nutraceutical, cosmetic and pharmaceutical applications. With the new process, production of Omega-3 and Astaxanthin will not affect marine resources. Both products will be free of pollutants, without fishy aftertaste and odour free, apt for vegans, and with competitive and stable production costs.
The SME Bicosome has developed a novel biomimetic and biocompatible skin delivery technology with outstanding capabilities of protecting antioxidant molecules from degradation, preserving and boosting their efficacy in the cutaneous tissue. This technology introduces an innovative mechanism of interaction with the skin, allowing for a very precise delivery of the active ingredients in specific skin levels. This allows obtaining high performance dermopharmaceutical products containing the bioactives Omega-3 and Astaxanthin for the treatment of complex skin disorders.
After the feasibility of the new products has been proved at a technical and market level, this SME-2 project will scale-up the production of both compounds and will demonstrate their effectiveness through their inclusion in nutraceuticals and in new ecological products for the treatment of 3 skin diseases: acne, atopic skin and aging skin produced by the SME Bicosome.
Both companies will very happy to develop their business all around Europe.
- 1,9 M€ project budget
- 70% EU grant
- 738661 agreement number
- 10 new products (nutraceutical/cosmetic)
- 5 employment creation
Neoalgae is a technology-based company which is active in the biotechnology of microalgae, with headquarters in Asturias.
Aquaculture: For use in aquaculture, they have a wide variety of species of microalgae grown in Spain, to feed live prey and larvae.
Aquariology: They offer different microalgae products grown in Spain.
Nutrition: Microalgae, considered by some as superfoods, provide significant benefits to our health.
Cosmetics: They don´t limit the use of microalgae to the field of feeding, because they also provide numerous benefits in skin care.
Bicosome is a start-up company that develops and commercializes high performance cosmetic and dermopharmaceutical ingredients based on a patented proprietary platform, the Bicosome® Technology.
Bicosome® Technology has a breakthrough mechanism for skin delivery, which combines the most attractive properties of existing lipid systems but far exceeds their capabilities and avoids their drawbacks.
In Bicosome® strategy both active ingredient and carrier work together in synergy to produce an outstanding result.